We have located links that may give you full text access.
Interactive Tutorial
Research Support, Non-U.S. Gov't
Risks and benefits of available treatments for adult ADHD.
Journal of Clinical Psychiatry 2011 March
Several pharmacotherapeutic options, both FDA-approved and off-label, exist for the treatment of adult ADHD. The most commonly used agents include several stimulants and atomoxetine, which have demonstrated significant, though similar, efficacy for ADHD versus placebo. Treatment should be selected according to patient comorbidity profiles, cardiovascular risks, and risk of abuse of prescription medications. In this activity, treatments for ADHD with and without comorbidity are discussed, including mechanisms of action, safety risks, and the potential for substance abuse. Implementing psychosocial education in conjunction with pharmacotherapy is recommended.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app